<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html><head><meta http-equiv="content-type" content="text/html; charset=utf-8"/><meta name="viewport" content="width=device-width, initial-scale=0.8"/><title>Cardiovasculaire et Strategies anti-infectieuses</title><link rel="stylesheet" type="text/css" href="scribble.css" title="default"/><link rel="stylesheet" type="text/css" href="manual-style.css" title="default"/><link rel="stylesheet" type="text/css" href="manual-racket.css" title="default"/><script type="text/javascript" src="scribble-common.js"></script><script type="text/javascript" src="manual-racket.js"></script><!--[if IE 6]><style type="text/css">.SIEHidden { overflow: hidden; }</style><![endif]--></head><body id="scribble-racket-lang-org"><div class="tocset"><div class="tocview"><div class="tocviewlist tocviewlisttopspace"><div class="tocviewtitle"><table cellspacing="0" cellpadding="0"><tr><td style="width: 1em;"><a href="javascript:void(0);" title="Expand/Collapse" class="tocviewtoggle" onclick="TocviewToggle(this,&quot;tocview_0&quot;);">&#9658;</a></td><td></td><td><a href="" class="tocviewselflink" data-pltdoc="x">Cardiovasculaire et Strategies anti-<wbr></wbr>infectieuses</a></td></tr></table></div><div class="tocviewsublistonly" style="display: none;" id="tocview_0"><table cellspacing="0" cellpadding="0"><tr><td align="right">1&nbsp;</td><td><a href="#%28part._.Antifongiques%29" class="tocviewlink" data-pltdoc="x">Antifongiques</a></td></tr><tr><td align="right">2&nbsp;</td><td><a href="#%28part._.Antihypertenseurs%29" class="tocviewlink" data-pltdoc="x">Antihypertenseurs</a></td></tr><tr><td align="right">3&nbsp;</td><td><a href="#%28part._.Hypolipemiants%29" class="tocviewlink" data-pltdoc="x">Hypolipemiants</a></td></tr></table></div></div></div><div class="tocsub"><table class="tocsublist" cellspacing="0"><tr><td><span class="tocsublinknumber"></span><a href="#%28part._.Cardiovasculaire_et_.Strategies_anti-infectieuses%29" class="tocsubseclink" data-pltdoc="x">Cardiovasculaire et Strategies anti-<wbr></wbr>infectieuses</a></td></tr><tr><td><span class="tocsublinknumber">1<tt>&nbsp;</tt></span><a href="#%28part._.Antifongiques%29" class="tocsubseclink" data-pltdoc="x">Antifongiques</a></td></tr><tr><td><span class="tocsublinknumber">1.1<tt>&nbsp;</tt></span><a href="#%28part._.Mycoses_superficielles%29" class="tocsubseclink" data-pltdoc="x">Mycoses superficielles</a></td></tr><tr><td><span class="tocsublinknumber">1.2<tt>&nbsp;</tt></span><a href="#%28part._.Antifongiques_d_origine_biologique%29" class="tocsubseclink" data-pltdoc="x">Antifongiques <span style="font-style: italic">d&rsquo;origine biologique</span></a></td></tr><tr><td><span class="tocsublinknumber">1.2.1<tt>&nbsp;</tt></span><a href="#%28part._polyenes%29" class="tocsubseclink" data-pltdoc="x">Polyenes</a></td></tr><tr><td><span class="tocsublinknumber">1.2.2<tt>&nbsp;</tt></span><a href="#%28part._griseofulvin%29" class="tocsubseclink" data-pltdoc="x">Griseofulvine</a></td></tr><tr><td><span class="tocsublinknumber">1.2.2.1<tt>&nbsp;</tt></span><a href="#%28part._griseofulvin._ma%29" class="tocsubseclink" data-pltdoc="x">Mecanisme d&rsquo;action</a></td></tr><tr><td><span class="tocsublinknumber">1.2.2.2<tt>&nbsp;</tt></span><a href="#%28part._.Effets_indesirables%29" class="tocsubseclink" data-pltdoc="x">Effets indesirables</a></td></tr><tr><td><span class="tocsublinknumber">1.2.2.3<tt>&nbsp;</tt></span><a href="#%28part._griseofulvin._iam%29" class="tocsubseclink" data-pltdoc="x">Interactions medicamenteuses</a></td></tr><tr><td><span class="tocsublinknumber">1.2.2.4<tt>&nbsp;</tt></span><a href="#%28part._griseofulvin._ind%29" class="tocsubseclink" data-pltdoc="x">Indications</a></td></tr><tr><td><span class="tocsublinknumber">2<tt>&nbsp;</tt></span><a href="#%28part._.Antihypertenseurs%29" class="tocsubseclink" data-pltdoc="x">Antihypertenseurs</a></td></tr><tr><td><span class="tocsublinknumber">2.1<tt>&nbsp;</tt></span><a href="#%28part._sartans%29" class="tocsubseclink" data-pltdoc="x">Sartans</a></td></tr><tr><td><span class="tocsublinknumber">2.1.1<tt>&nbsp;</tt></span><a href="#%28part._sartan._pk%29" class="tocsubseclink" data-pltdoc="x">Pharmacocinetique</a></td></tr><tr><td><span class="tocsublinknumber">2.1.2<tt>&nbsp;</tt></span><a href="#%28part._iec._ei%29" class="tocsubseclink" data-pltdoc="x">Effets indesirables</a></td></tr><tr><td><span class="tocsublinknumber">2.1.3<tt>&nbsp;</tt></span><a href="#%28part._iec._ind%29" class="tocsubseclink" data-pltdoc="x">Indications</a></td></tr><tr><td><span class="tocsublinknumber">2.1.4<tt>&nbsp;</tt></span><a href="#%28part._iec._ci%29" class="tocsubseclink" data-pltdoc="x">Contre-<wbr></wbr>indications</a></td></tr><tr><td><span class="tocsublinknumber">2.2<tt>&nbsp;</tt></span><a href="#%28part._iec%29" class="tocsubseclink" data-pltdoc="x">Inhibiteurs de l&rsquo;enzyme de conversion</a></td></tr><tr><td><span class="tocsublinknumber">2.2.1<tt>&nbsp;</tt></span><a href="#%28part._iec._ma%29" class="tocsubseclink" data-pltdoc="x">Mecanisme d&rsquo;action</a></td></tr><tr><td><span class="tocsublinknumber">3<tt>&nbsp;</tt></span><a href="#%28part._.Hypolipemiants%29" class="tocsubseclink" data-pltdoc="x">Hypolipemiants</a></td></tr><tr><td><span class="tocsublinknumber">3.1<tt>&nbsp;</tt></span><a href="#%28part._.Statines%29" class="tocsubseclink" data-pltdoc="x">Statines</a></td></tr><tr><td><span class="tocsublinknumber">3.1.1<tt>&nbsp;</tt></span><a href="#%28part.__.Statines_d_origine_hemisynthetique_%29" class="tocsubseclink" data-pltdoc="x"> Statines d&rsquo;origine hemisynthetique </a></td></tr><tr><td><span class="tocsublinknumber">3.1.2<tt>&nbsp;</tt></span><a href="#%28part.__.Statines_d_origine_synthetique_%29" class="tocsubseclink" data-pltdoc="x"> Statines d&rsquo;origine synthetique </a></td></tr></table></div></div><div class="maincolumn"><div class="main"><div class="versionbox"><span class="versionNoNav">7.9</span></div><h2><a name="(part._.Cardiovasculaire_et_.Strategies_anti-infectieuses)"></a>Cardiovasculaire et Strategies anti-infectieuses</h2><div class="SAuthorListBox"><span class="SAuthorList"><p class="author">Youssef Sahli</p></span></div><blockquote class="refpara"><blockquote class="refcolumn"><blockquote class="refcontent"><p><span style="font-weight: bold">14 janvier 13h</span>:
 <br/>
Strategie anti infectieuse
Cardiovasculaire
<br/>
<span style="font-style: italic">Auditorium</span></p></blockquote></blockquote></blockquote><table cellspacing="0" cellpadding="0"><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Antifongiques%29" class="toptoclink" data-pltdoc="x">1<span class="hspace">&nbsp;</span>Antifongiques</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Mycoses_superficielles%29" class="toclink" data-pltdoc="x">1.1<span class="hspace">&nbsp;</span>Mycoses superficielles</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Antifongiques_d_origine_biologique%29" class="toclink" data-pltdoc="x">1.2<span class="hspace">&nbsp;</span>Antifongiques <span style="font-style: italic">d&rsquo;origine biologique</span></a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._polyenes%29" class="toclink" data-pltdoc="x">1.2.1<span class="hspace">&nbsp;</span>Polyenes</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._griseofulvin%29" class="toclink" data-pltdoc="x">1.2.2<span class="hspace">&nbsp;</span>Griseofulvine</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._griseofulvin._ma%29" class="toclink" data-pltdoc="x">1.2.2.1<span class="hspace">&nbsp;</span>Mecanisme d&rsquo;action</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Effets_indesirables%29" class="toclink" data-pltdoc="x">1.2.2.2<span class="hspace">&nbsp;</span>Effets indesirables</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._griseofulvin._iam%29" class="toclink" data-pltdoc="x">1.2.2.3<span class="hspace">&nbsp;</span>Interactions medicamenteuses</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._griseofulvin._ind%29" class="toclink" data-pltdoc="x">1.2.2.4<span class="hspace">&nbsp;</span>Indications</a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Antihypertenseurs%29" class="toptoclink" data-pltdoc="x">2<span class="hspace">&nbsp;</span>Antihypertenseurs</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._sartans%29" class="toclink" data-pltdoc="x">2.1<span class="hspace">&nbsp;</span>Sartans</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._sartan._pk%29" class="toclink" data-pltdoc="x">2.1.1<span class="hspace">&nbsp;</span>Pharmacocinetique</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._iec._ei%29" class="toclink" data-pltdoc="x">2.1.2<span class="hspace">&nbsp;</span>Effets indesirables</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._iec._ind%29" class="toclink" data-pltdoc="x">2.1.3<span class="hspace">&nbsp;</span>Indications</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._iec._ci%29" class="toclink" data-pltdoc="x">2.1.4<span class="hspace">&nbsp;</span>Contre-indications</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._iec%29" class="toclink" data-pltdoc="x">2.2<span class="hspace">&nbsp;</span>Inhibiteurs de l&rsquo;enzyme de conversion</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._iec._ma%29" class="toclink" data-pltdoc="x">2.2.1<span class="hspace">&nbsp;</span>Mecanisme d&rsquo;action</a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Hypolipemiants%29" class="toptoclink" data-pltdoc="x">3<span class="hspace">&nbsp;</span>Hypolipemiants</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Statines%29" class="toclink" data-pltdoc="x">3.1<span class="hspace">&nbsp;</span>Statines</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part.__.Statines_d_origine_hemisynthetique_%29" class="toclink" data-pltdoc="x">3.1.1<span class="hspace">&nbsp;</span> Statines d&rsquo;origine hemisynthetique </a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part.__.Statines_d_origine_synthetique_%29" class="toclink" data-pltdoc="x">3.1.2<span class="hspace">&nbsp;</span> Statines d&rsquo;origine synthetique </a></p></td></tr></table><h3>1<tt>&nbsp;</tt><a name="(part._.Antifongiques)"></a>Antifongiques</h3><h4>1.1<tt>&nbsp;</tt><a name="(part._.Mycoses_superficielles)"></a>Mycoses superficielles</h4><p><table cellspacing="0" cellpadding="0" class="boxed" style="border-collapse: collapse;"><tr><td align="center" style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">Dermatophyties</span></p></td><td align="center" style="border-bottom: 1px solid black;"><p></p></td><td align="center" style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">Pytirosporoses</span></p></td><td align="center" style="border-bottom: 1px solid black;"><p></p></td><td align="center" style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">Candidoses</span></p></td></tr><tr><td align="center"><p>Epidermophyton</p></td><td align="center"><p></p></td><td align="center"><p>Malassezia furfur</p></td><td align="center"><p></p></td><td align="center"><p>Candida sp</p></td></tr><tr><td align="center"><p>Teignes</p></td><td align="center"><p></p></td><td align="center"><p>Pytiriasis versicolor</p></td><td align="center"><p></p></td><td align="center"><p>muguet, perleche</p></td></tr><tr><td align="center"><p>Herpes circine</p></td><td align="center"><p></p></td><td align="center"><p>Dermite seborreique</p></td><td align="center"><p></p></td><td align="center"><p>Balanite, vulvovaginite</p></td></tr><tr><td align="center"><p><span style="font-style: italic">Acide undecylenique</span></p></td><td align="center"><p></p></td><td align="center"><p><span style="font-style: italic">Sulfure de selenium</span></p></td><td align="center"><p></p></td><td align="center"><p></p></td></tr></table></p><h4>1.2<tt>&nbsp;</tt><a name="(part._.Antifongiques_d_origine_biologique)"></a>Antifongiques <span style="font-style: italic">d&rsquo;origine biologique</span></h4><h5>1.2.1<tt>&nbsp;</tt><a name="(part._polyenes)"></a>Polyenes</h5><p><img src="amphotericin.png" alt="Amphotericin B" width="280" height="142"/></p><h5>1.2.2<tt>&nbsp;</tt><a name="(part._griseofulvin)"></a>Griseofulvine</h5><p>Elle est derivee du Benzodihydrofurane
C&rsquo;est un poison du fuseau actif sur tous les dermatophytes</p><h5>1.2.2.1<tt>&nbsp;</tt><a name="(part._griseofulvin._ma)"></a>Mecanisme d&rsquo;action</h5><ul><li><p>Inhibition de la synthese des acides nucleiques</p></li><li><p>inhibition de la synth de la paroi fongique</p></li><li><p>Blocage de la mitose</p></li><li><p>Perturbation du trp du cytoplasme vers la peripherie</p></li></ul><h5>1.2.2.2<tt>&nbsp;</tt><a name="(part._.Effets_indesirables)"></a>Effets indesirables</h5><p><div class="SIntrapara"><span style="font-style: italic">Bien toleree generalement</span>
</div><div class="SIntrapara"><ul><li><p>Cephalees</p></li><li><p>Vertiges</p></li><li><p>Confusion</p></li><li><p>Nausees, vomissements</p></li><li><p>effets cutanes et photosensibilisation</p></li></ul></div></p><h5>1.2.2.3<tt>&nbsp;</tt><a name="(part._griseofulvin._iam)"></a>Interactions medicamenteuses</h5><ul><li><p>Deconseillee avec les oestroprogestatifs</p></li><li><p>Effet antabuse avec l&rsquo;alcool</p></li></ul><h5>1.2.2.4<tt>&nbsp;</tt><a name="(part._griseofulvin._ind)"></a>Indications</h5><ul><li><p>Teignes</p></li><li><p>Dermatophytoses</p></li></ul><h3>2<tt>&nbsp;</tt><a name="(part._.Antihypertenseurs)"></a>Antihypertenseurs</h3><h4>2.1<tt>&nbsp;</tt><a name="(part._sartans)"></a>Sartans</h4><p>Antagonistes competitifs reversibles des recepteurs a
l&rsquo;angiotensine II <span style="font-style: italic">R.AT1</span></p><p><table cellspacing="0" cellpadding="0" class="boxed" style="border-collapse: collapse;"><tr><td style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">AT1</span></p></td><td style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">AT2</span></p></td></tr><tr><td><p>Vasodilation</p></td><td><p>Vasodilatation</p></td></tr><tr><td><p>Reabsorption Na H2O</p></td><td><p>Natriurese</p></td></tr><tr><td><p>Stimulation de la proliferation cellulaire</p></td><td><p>Inhibition de la proliferation cellulaire</p></td></tr></table></p><h5>2.1.1<tt>&nbsp;</tt><a name="(part._sartan._pk)"></a>Pharmacocinetique</h5><ul><li><p>Resorption digestive bonne</p></li><li><p>1er passage hepatique fort avec un metabolite actif</p></li><li><p>LPP forte</p></li><li><p>Elimination urinaire et biliaire (mixte)</p></li></ul><h5>2.1.2<tt>&nbsp;</tt><a name="(part._iec._ei)"></a>Effets indesirables</h5><ul><li><p>Hypotension dose-dependante</p></li><li><p>Deterioration de la fonction renale</p></li><li><p>Hyperkaliemie, Hyperuricemie</p></li><li><p>Angioedeme</p></li></ul><h5>2.1.3<tt>&nbsp;</tt><a name="(part._iec._ind)"></a>Indications</h5><ul><li><p>Candesartan: <a href="https://www.icm-mhi.org/fr/soins-et-services/maladies-cardiovasculaires/insuffisance-cardiaque">Insuffisance cardiaque</a></p></li></ul><h5>2.1.4<tt>&nbsp;</tt><a name="(part._iec._ci)"></a>Contre-indications</h5><p>absolue: Grossesse
relative:
<a href="https://fr.wikipedia.org/wiki/St%C3%A9nose"> Stenose</a>
bilaterale des arteres renales</p><h4>2.2<tt>&nbsp;</tt><a name="(part._iec)"></a>Inhibiteurs de l&rsquo;enzyme de conversion</h4><h5>2.2.1<tt>&nbsp;</tt><a name="(part._iec._ma)"></a>Mecanisme d&rsquo;action</h5><p>Inhibiteurs de la synthese d&rsquo;angiotensine II.
La cascade enzymatique est inhibee,
de la <span style="font-style: italic">synthese</span> d&rsquo;aldosterone a la <span style="font-style: italic">degradation</span> de bradykinine</p><h3>3<tt>&nbsp;</tt><a name="(part._.Hypolipemiants)"></a>Hypolipemiants</h3><h4>3.1<tt>&nbsp;</tt><a name="(part._.Statines)"></a>Statines</h4><h5>3.1.1<tt>&nbsp;</tt><a name="(part.__.Statines_d_origine_hemisynthetique_)"></a> Statines d&rsquo;origine hemisynthetique </h5><ul><li><p>Simvastatine ZOCOR </p></li><li><p>Pravastatine ELISOR</p></li></ul><h5>3.1.2<tt>&nbsp;</tt><a name="(part.__.Statines_d_origine_synthetique_)"></a> Statines d&rsquo;origine synthetique </h5><ul><li><p>Fluvastatine FRACTAL</p></li><li><p>Rosuvastatine CRESTOR</p></li><li><p>Atorvastatine TAHOR</p></li></ul></div></div><div id="contextindicator">&nbsp;</div></body></html>